SEC Form 4 · accession 0001140361-16-050158
WINDTREE THERAPEUTICS INC /DE/ · WINT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig Fraser
Officer — President and CEO · Director
Period of report
Feb 1, 2016
Accepted (ET)
Feb 3, 2016 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)F1,F2 | $2.33 | Feb 1, 2016 | A | 204,863 | A | Feb 1, 2017 | Feb 1, 2026 | Common Stock | 204,863 | 204,863 | D |
Explanation of responses
- F1In accordance with Nasdaq Listing Rule 5635(c)(4), on February 1, 2016, which was the initial date of employment, upon recommendation of the Company, the Compensation Committee granted to Mr. Fraser an inducement option to purchase 204,863 shares of the Common Stock at an exercise price of $2.33 per share, the closing price on February 2, 2016 and the closing price next determined after approval of the grant.
- F2This employee stock option shall vest in a series of three successive, equal installments beginning with the first anniversary of the grant.